Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
European Journal of Biochemistry
|
April 1, 1985
Use of tyrosine-containing polymers to characterize the substrate specificity of insulin and other hormone-stimulated tyrosine kinases
Y Zick, G Grunberger, R W Rees-Jones, et al.
Annals of Internal Medicine
|
January 1, 1989
NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut
P Gorden, R J Comi, P N Maton, et al.
The New England Journal of Medicine
|
July 2, 1987
Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue
R J Comi, N Gesundheit, L Murray, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 26, 2001
Efficacy of insulin pump therapy: mealtime delivery is the key factor
L M Crawford, R N Sinha, R M Odell, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1995
The effect of cigarette smoking on adrenal cortical hormones
J A Baron, R J Comi, V Cryns, et al.
Clinical Endocrinology
|
March 1, 1992
A prospective examination of octreotide-induced gall-bladder changes in acromegaly
R C Eastman, R F Arakaki, T Shawker, et al.
The Journal of Laboratory and Clinical Medicine
|
July 1, 1988
Insulin receptor tyrosine kinase activity is abnormal in circulating cells and cultured fibroblasts but normal in transformed lymphocytes from a type A insulin-resistant patient
G Grunberger, R J Comi, J L Carpentier, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
European Journal of Biochemistry
|
April 1, 1985
Use of tyrosine-containing polymers to characterize the substrate specificity of insulin and other hormone-stimulated tyrosine kinases
Y Zick, G Grunberger, R W Rees-Jones, et al.
Annals of Internal Medicine
|
January 1, 1989
NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut
P Gorden, R J Comi, P N Maton, et al.
The New England Journal of Medicine
|
July 2, 1987
Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue
R J Comi, N Gesundheit, L Murray, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
June 26, 2001
Efficacy of insulin pump therapy: mealtime delivery is the key factor
L M Crawford, R N Sinha, R M Odell, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1995
The effect of cigarette smoking on adrenal cortical hormones
J A Baron, R J Comi, V Cryns, et al.
Clinical Endocrinology
|
March 1, 1992
A prospective examination of octreotide-induced gall-bladder changes in acromegaly
R C Eastman, R F Arakaki, T Shawker, et al.
The Journal of Laboratory and Clinical Medicine
|
July 1, 1988
Insulin receptor tyrosine kinase activity is abnormal in circulating cells and cultured fibroblasts but normal in transformed lymphocytes from a type A insulin-resistant patient
G Grunberger, R J Comi, J L Carpentier, et al.
Page
of 2